Cheshire, CT, United States of America

Salvatore Forenza



Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Chesire, CT (US) (1992)
  • Cheshire, CT (US) (1991 - 1995)

Company Filing History:


Years Active: 1991-1995

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Salvatore Forenza

Introduction

Salvatore Forenza is a remarkable inventor based in Cheshire, CT, who has made significant contributions to the field of pharmaceutical innovations. With a total of five patents to his name, Forenza's work primarily focuses on developing novel antitumor agents that showcase promising therapeutic properties.

Latest Patents

Among the latest innovations attributed to Forenza are two groundbreaking patents. The first is for "Rebeccamycin analogs by tryptophan analogs feeding." This invention details a method where the addition of specific tryptophan analogs during the fermentation process of a rebeccamycin-producing strain of Saccharothrix aerocolonigenes leads to the generation of new rebeccamycin analogs with enhanced antitumor capabilities. His second patent, "Antitumor antibiotic BMY-41219," involves the fermentation of Saccharothrix aerocolonigenes ATCC 39243 to produce the antibiotic BMY-41219, which has shown significant antitumor activity.

Career Highlights

Forenza's career has been marked by his association with prestigious pharmaceutical companies. He has worked at Bristol-Myers Squibb Company and Bristol-Myers Company, where he has contributed to the development of innovative healthcare solutions.

Collaborations

Throughout his career, Forenza has collaborated with notable colleagues, including Kin S. Lam and James A. Matson. These partnerships have undoubtedly played a role in the success of his research and inventions, fostering an environment of creativity and innovation.

Conclusion

Salvatore Forenza exemplifies the spirit of innovation in the pharmaceutical field. His patents reflect a commitment to advancing medical science and improving patient outcomes through groundbreaking research and collaboration. As a leading inventor, Forenza continues to pave the way for future developments in antitumor therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…